Carlos Pavesio, EURETINA 2021: Fluocinolone Acetonide Insert for Noninfectious Uveitis
It was great to speak with Carlos Pavesio (Moorfields Eye Hospital, London, UK) about unmet needs in treatment of noninfectious uveitis, and the clinical evidence supporting the efficacy of the fluocinolone acetonide insert.
- What are the unmet needs in the treatment of noninfectious uveitis? (00:33)
- Could you tell us a little about the fluocinolone acetonide insert and the clinical evidence supporting its use in noninfectious uveitis? (02:13)
Speaker Disclosure: Carlos Pavesio has no financial or non-financial relationships or activities to declare in relation to this interview.
Support: Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Lisa Glass.
Filmed in coverage of EURETINA 2021.
Share this Video
Related Videos In Ocular Immunology
Lisa Sarfaty: Help support Rare Disease Day
Our society partner, NORD (The National Organization for Rare Disorder) has planned several initiatives to support this year’s Rare Disease Day on 28 February. These activities are aimed at raising awareness about rare diseases and the challenges faced by people living with these conditions. In this video, Lisa Sarfaty, NORD’s VP of Communication and Engagement, […]
Lisa Sarfaty: Exploring and addressing inequities in rare diseases
Rare diseases can present numerous challenges for those living with these conditions and the healthcare professionals caring for them. In this interview we discuss some of these with Lisa Sarfaty, VP of Communication and Engagement for NORD (The National Organization for Rare Disorders) and explore ways in which they could be tackled. Questions Could you […]
Carlos Pavesio, EURETINA 2021: Fluocinolone Acetonide Insert – A Study
We were delighted to catch up with Carlos Pavesio (Moorfields Eye Hospital, London, UK), who shared details of his study to evaluate the safety and efficacy of the fluocinolone acetonide insert for the treatment of noninfectious uveitis. Questions: What were the aims and design of your recent study? (00:31) What were the efficacy and safety […]
Journal articles and more to your inbox
Get the latest clinical insights from touchOPHTHALMOLOGYSign me up!